Insider Trading May 4, 2026 06:37 PM

Orion Group Holdings Director Executes Stock Dispositions Amid Recent Price Appreciation

Director Margaret Foran liquidates 30,000 shares as ORN approaches annual highs following a significant quarterly earnings beat.

By Hana Yamamoto ORN
Orion Group Holdings Director Executes Stock Dispositions Amid Recent Price Appreciation
ORN

Margaret Foran, a member of the Board of Directors at Orion Group Holdings Inc. (NASDAQ:ORN), has completed two separate transactions involving the sale of common stock earlier this month. The total value of these disposals reached $438,600. These sales occur during a period of significant upward momentum for ORN, which is currently trading near its 52-week high of $15 and has seen its share price increase by over 100% over the last twelve months. Despite recent strong financial performance, valuation metrics suggest the stock may be trading above its fair value.

Key Points

  • Director Margaret Foran sold 30,000 shares in two separate transactions in early May at a weighted average price of $14.62 per share.
  • Orion Group Holdings demonstrated exceptional operational strength in Q1 2026, with EPS of $0.05 beating forecasts by over 963% and revenue exceeding expectations by 9.18%.
  • The company's stock has seen significant appreciation, rising over 100% in the past year and 47% year-to-date, approaching its 52-week high of $15.

Recent regulatory filings from the Securities and Exchange Commission (SEC) reveal that Margaret Foran, a director at Orion Group Holdings Inc. (NASDAQ:ORN), has engaged in two distinct transactions to sell portions of her holdings in the company. In total, Ms. Foran disposed of 30,000 shares of common stock, generating proceeds amounting to $438,600.

The first transaction occurred on May 1, during which Ms. Foran sold 20,000 shares. The prices for these specific shares fluctuated between $14.55 and $14.73 per share, resulting in a reported weighted average price of $14.62 per share. Following this, on May 4, a second transaction was completed involving the sale of an additional 10,000 shares. These secondary sales were executed at prices ranging from $14.60 to $14.70 per share, also maintaining a weighted average price of $14.62 per share.


Following these recent divestments, Ms. Foran retains a direct ownership stake of 127,541 shares in Orion Group Holdings common stock. This insider activity takes place against a backdrop of substantial market movement for the company's equity. The stock is currently trading near its 52-week high of $15, marking an increase of more than 100% over the past year. Furthermore, ORN has experienced a 47% surge in value since the beginning of the current year.

While the stock's price trajectory has been aggressive, analysis from InvestingPro suggests that the shares may currently be overvalued when evaluated against Fair Value metrics. This valuation perspective stands in contrast to the company's recent operational achievements, as Orion Group Holdings reported highly robust financial results for the first quarter of 2026.

The quarterly performance significantly exceeded market expectations on two primary fronts: earnings and revenue. The company posted an earnings per share (EPS) of $0.05, a figure that represents a 963.83% increase over the forecasted amount of $0.0047. In terms of top-line growth, Orion Group Holdings reported quarterly revenue of $216.3 million. This outperformed the projected revenue of $198.12 million by a margin of 9.18%. These results have contributed to positive momentum and have drawn scrutiny from various analyst firms as investors monitor the company's ongoing financial health.

Risks

  • Valuation risk: Despite strong performance, current Fair Value metrics suggest the stock may be overvalued at its recent trading levels.
  • Market volatility risk: With shares trading near a 52-week high after massive annual gains, the stock remains subject to market corrections.

More from Insider Trading

Marcus & Millichap Director Executes Substantial Common Stock Purchase May 4, 2026 Patterson-UTI CEO Executes Multi-Million Dollar Stock Sale Amidst Year-to-Date Surge May 4, 2026 Snowflake Director Michael Speiser Executes $7.18 Million in Stock Sales May 4, 2026 Edwards Lifesciences Executive Executes Stock Transactions Amid Recent Financial Growth May 4, 2026 Entrada Therapeutics President and COO Executes Stock Sale via Rule 10b5-1 Plan May 4, 2026